Health utility scores of family caregivers for leukemia patients measured by EQ-5D-3L: a cross-sectional survey in China

Yu, Hongjuan; Zhang, Huan; Yang, Jinjin; Liu, Chaojie; Lu, Chengfang; Yang, Hongbin; Huang, Weidong; Zhou, Jin; Fu, Wenqi; Shi, Linmei; Yan, Yan; Liu, Guoxiang; Li, Limin

doi:10.1186/s12885-018-4855-y

Table 2 Health utility scores of family caregivers

From: Health utility scores of family caregivers for leukemia patients measured by EQ-5D-3L: a cross-sectional survey in China

Characteristics	Number	Mean ± SD	Median (range)	p
Family caregivers
Gender				0.546
Male	139	0.81 ± 0.19	0.87 (0.29–1.00)
Female	167	0.83 ± 0.15	0.87 (0.29–1.00)
Age (years)				0.092
≤40	154	0.83 ± 0.16	0.87 (0.29–1.00)
>40	152	0.80 ± 0.17	0.80 (0.33–1.00)
Relationship to patient				0.010
Spouse	114	0.78 ± 0.19	0.80 (0.29–1.00)
Parent	133	0.83 ± 0.15	0.87 (0.33–1.00)
Child	43	0.85 ± 0.17	0.88 (0.29–1.00)
Other	16	0.91 ± 0.14	1.00 (0.61–1.00)
Level of education				0.106
No more than primary school	38	0.78 ± 0.16	0.78 (0.51–1.00)
Middle or high school	202	0.82 ± 0.18	0.87 (0.29–1.00)
University	66	0.85 ± 0.14	0.87 (0.40–1.00)
Ethnicity				0.386
Han	296	0.82 ± 0.17	0.87 (0.29–1.00)
Other	10	0.87 ± 0.12	0.88 (0.71–1.00)
Religious belief				0.077
No	260	0.81 ± 0.17	0.87 (0.29–1.00)
Yes	46	0.87 ± 0.14	0.88 (0.51–1.00)
Marital status				0.724
Married	288	0.82 ± 0.17	0.87 (0.29–1.00)
Other	18	0.85 ± 0.11	0.87 (0.61–1.00)
Duration of caregiving (Months)				0.856
≤6	109	0.81 ± 0.19	0.87 (0.29–1.00)
7–12	69	0.84 ± 0.15	0.87 (0.29–1.00)
13–24	70	0.81 ± 0.16	0.80 (0.41–1.00)
>24	58	0.82 ± 0.16	0.87 (0.41–1.00)
Time spent caregiving per day (Hours)				0.037
0–12	126	0.83 ± 0.19	0.88 (0.29–1.00)
13–24	180	0.81 ± 0.16	0.80 (0.29–1.00)
Understanding of the disease				0.606
Lacking	7	0.78 ± 0.16	0.76 (0.53–1.00)
Partial	190	0.81 ± 0.18	0.83 (0.29–1.00)
Fully	109	0.83 ± 0.16	0.87 (0.33–1.00)
Annual household income (Yuan)				0.002
≤40,000	165	0.79 ± 0.17	0.78 (0.29–1.00)
40,001–79,999	131	0.85 ± 0.17	0.88 (0.29–1.00)
≥80,000	10	0.83 ± 0.16	0.87 (0.53–1.00)
Employment				0.021
Employed	236	0.83 ± 0.17	0.87 (0.29–1.00)
Retired	22	0.71 ± 0.20	0.77 (0.41–1.00)
Unemployed	48	0.82 ± 0.14	0.79 (0.47–1.00)
Anxiety (HADS score)				0.063
Normal	23	0.88 ± 0.15	0.88 (0.51–1.00)
Mild	118	0.83 ± 0.18	0.88 (0.29–1.00)
Moderate	148	0.80 ± 0.16	0.78 (0.29–1.00)
Severe	17	0.81 ± 0.17	0.78 (0.51–1.00)
Depression (HADS score)				0.393
Normal	120	0.82 ± 0.19	0.87 (0.29–1.00)
Mild	145	0.82 ± 0.15	0.87 (0.29–1.00)
Moderate	41	0.79 ± 0.16	0.78 (0.33–1.00)
Social support (SSRSG score)				0.000
Low	153	0.76 ± 0.17	0.78 (0.29–1.00)
High	153	0.88 ± 0.14	0.88 (0.50–1.00)
Family function (APGAR score)				0.000
Severely dysfunctional	74	0.75 ± 0.18	0.78 (0.29–1.00)
Moderate dysfunctional	155	0.82 ± 0.16	0.87 (0.29–1.00)
Highly functional	77	0.89 ± 0.15	1.00 (0.50–1.00)
Patients
Gender				0.381
Male	144	0.81 ± 0.17	0.80 (0.29–1.00)
Female	162	0.82 ± 0.17	0.87 (0.29–1.00)
Age(years)				0.303
<15	72	0.81 ± 0.15	0.79 (0.33–1.00)
≥15	234	0.82 ± 0.18	0.87 (0.29–1.00)
Ethnicity				0.326
Han	292	0.82 ± 0.17	0.87 (0.29–1.00)
Other	14	0.86 ± 0.16	0.88 (0.41–1.00)
Types of leukemia				0.037
All	93	0.83 ± 0.15	0.87 (0.29–1.00)
AML	163	0.83 ± 0.18	0.87 (0.29–1.00)
CLL	8	0.66 ± 0.17	0.73 (0.41–1.00)
CML	42	0.80 ± 0.18	0.78 (0.29–1.00)
Duration since diagnosis (months)				0.258
0–6	36	0.79 ± 0.19	0.78 (0.29–1.00)
7–12	82	0.83 ± 0.19	0.88 (0.29–1.00)
12–24	91	0.81 ± 0.17	0.78 (0.29–1.00)
>24	97	0.82 ± 0.15	0.87 (0.41–1.00)
Medical insurance				0.092
No	278	0.77 ± 0.17	0.78 (0.41–1.00)
Yes	28	0.82 ± 0.17	0.87 (0.29–1.00)

Back to article page

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com

BMC Cancer

Contact us